Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye
Conditions
- Neovascular Age-Related Macular Degeneration
Interventions
- DRUG: Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)
- DRUG: Aflibercept VEGF Trap-Eye (Eylea, BAY86-5321)
Sponsor
Bayer
Collaborators